661 related articles for article (PubMed ID: 25173681)
1. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
Pasternak B; Svanström H; Melbye M; Hviid A
JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis.
Shore S; Aggarwal V; Zolty R
J Card Fail; 2012 Dec; 18(12):919-24. PubMed ID: 23207080
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
[TBL] [Abstract][Full Text] [Related]
4. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
5. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study.
Fröhlich H; Zhao J; Täger T; Cebola R; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L
Circ Heart Fail; 2015 Sep; 8(5):887-96. PubMed ID: 26175538
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
[TBL] [Abstract][Full Text] [Related]
10. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
[TBL] [Abstract][Full Text] [Related]
11. Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.
Delea TE; Stanford R; Hagiwara M; Edelsberg JS; Oster G
Int J Cardiol; 2005 Mar; 99(1):117-24. PubMed ID: 15721509
[TBL] [Abstract][Full Text] [Related]
12. Discharge use of carvedilol is associated with higher survival in Japanese elderly patients with heart failure regardless of left ventricular ejection fraction.
Yanagihara K; Kinugasa Y; Sugihara S; Hirai M; Yamada K; Ishida K; Kato M; Yamamoto K
J Cardiovasc Pharmacol; 2013 Nov; 62(5):485-90. PubMed ID: 24072178
[TBL] [Abstract][Full Text] [Related]
13. Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
Remme WJ; Cleland JG; Erhardt L; Spark P; Torp-Pedersen C; Metra M; Komajda M; Moullet C; Lukas MA; Poole-Wilson P; Di Lenarda A; Swedberg K
Eur J Heart Fail; 2007 Nov; 9(11):1128-35. PubMed ID: 17716943
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
Massie BM; Nelson JJ; Lukas MA; Greenberg B; Fowler MB; Gilbert EM; Abraham WT; Lottes SR; Franciosa JA;
Am J Cardiol; 2007 May; 99(9):1263-8. PubMed ID: 17478155
[TBL] [Abstract][Full Text] [Related]
15. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure.
Briasoulis A; Palla M; Afonso L
Am J Cardiol; 2015 Apr; 115(8):1111-5. PubMed ID: 25708861
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
[TBL] [Abstract][Full Text] [Related]
18. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
[TBL] [Abstract][Full Text] [Related]
19. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
